Democrats urge FDA to test lipstick for lead

ADI-001 is an investigation allogeneic gamma delta chimeric antigen receptor T cell therapy that targets CD20 for the treatment of a variety of autoimmune diseases.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The therapy is now the first and only FDA-approved treatment that maintains vision with fewer treatments compared to standard-of-care injections.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

The approval makes Johnson and Johnson’s esketamine nasal spray the first and only monotherapy for the treatment of major depressive disorder in adult patients.

Using the DASH Rapid PCR System, providers can yield test results in under 1 minute of hands-on time.